What is Kymera Therapeutics's net income?

Kymera Therapeutics (KYMR) reported net income of -$69.23M in Q1 2026.

How has Kymera Therapeutics's net income changed year-over-year?

Kymera Therapeutics's net income decreased by 5.6% year-over-year, from -$65.58M to -$69.23M.

What is the long-term trend for Kymera Therapeutics's net income?

Over 4 years (2021 to 2025), Kymera Therapeutics's net income has grown at a 32.8% compound annual growth rate (CAGR), from -$100.22M to -$311.35M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Kymera Therapeutics KYMR Net Income

Net Income at other companies

PfizerPFE

$2.7B-9.3%

Johnson & JohnsonJNJ

$5.24B-52.4%

Regeneron PharmaceuticalsREGN

$727.2M-10.1%

ImmunityBio, Inc.IBRX

-$632.8M-388%

Krystal Biotech, Inc.KRYS

$55.93M+56.5%

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$34.4M+55.5%

Operating income-$84.2M-13.1%

Net income-$69.2M-5.6%

EPS (diluted)-$0.71+13.4%

Balance sheet

See full

Cash & equivalents$144.1M+60.2%

Total debt$82.2M-6.5%

Total equity$1.5B+95.8%

Total assets$1.7B+81.7%

Cash flow

See full

Operating cash flow-$88.8M-12.2%

CapEx$434.0K-7.1%

Free cash flow-$89.3M-12.1%

Valuation

See full

Market cap$7.44B+283%

Enterprise value$7.38B+280%

P/S144.5×+111×

Profitability

See full

Operating margin-697.7%+635pp

Net margin-612%+602pp

FCF margin-474%+92.4pp

Returns & leverage

See full

Return on equity-27.1%-3.7pp

Debt / equity0.1×-0.1×

Current ratio10.8×+2.3×

Where this comes from

Reported directly by Kymera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kymera Therapeutics's net income?: Kymera Therapeutics (KYMR) reported net income of -$69.23M in Q1 2026.
How has Kymera Therapeutics's net income changed year-over-year?: Kymera Therapeutics's net income decreased by 5.6% year-over-year, from -$65.58M to -$69.23M.
What is the long-term trend for Kymera Therapeutics's net income?: Over 4 years (2021 to 2025), Kymera Therapeutics's net income has grown at a 32.8% compound annual growth rate (CAGR), from -$100.22M to -$311.35M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.